Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 2, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             .

 

Commission file number 1-3246

 


 

ProQuest Company

(Exact name of registrant as specified in its charter)

 


 

Delaware   36-3580106

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. employer

identification no.)

300 North Zeeb Road, Ann Arbor, Michigan   48103-1553
(Address of principal executive offices)   (Zip code)

 

Registrant’s telephone number, including area code: (734) 761-4700

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).  x

 

The number of shares of the Registrant’s Common Stock, $.001 par value, outstanding as of November 9, 2004 was 28,586,706.

 



Table of Contents

TABLE OF CONTENTS

 

          Page

PART I

   FINANCIAL INFORMATION     

  Item 1.

  

Consolidated Financial Statements

    
    

Consolidated Statements of Operations for the Thirteen and Thirty-Nine Week Periods Ended October 2, 2004 and September 27, 2003

   1
    

Consolidated Balance Sheets as of October 2, 2004, January 3, 2004, and September 27, 2003

   2
    

Consolidated Statements of Cash Flows for the Thirty-Nine Week Periods Ended October 2, 2004 and September 27, 2003

   3
    

Notes to the Consolidated Financial Statements

   4

  Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   15

  Item 3.

  

Quantitative and Qualitative Disclosures about Market Risk

   28

  Item 4.

  

Controls and Procedures

   28

PART II

   OTHER INFORMATION     

  Item 1.

  

Legal Proceedings

   29

  Item 2.

  

Unregistered Sales of Equity Securities and use of Proceeds

   29

  Item 6.

  

Exhibits and Reports on Form 8-K

   29

SIGNATURE PAGE

   30

EXHIBITS

    

Certification of Chief Executive Officer - 302

   31

Certification of Chief Financial Officer - 302

   33

Certification of Chief Executive Officer - 906

   35

Certification of Chief Financial Officer - 906

   36

Multi-year Stock Option Grant

   37


Table of Contents

ProQuest Company and Subsidiaries

Consolidated Statements of Operations

For the Thirteen and Thirty-Nine Week Periods Ended October 2, 2004, and September 27, 2003

(In thousands, except per share data)

(Unaudited)

 

     Thirteen Weeks Ended

    Thirty-Nine Weeks Ended

 
    

October 2,

2004


   

September 27,

2003


   

October 2,

2004


   

September 27,

2003


 

Net sales

   $ 113,124     $ 112,300     $ 336,165     $ 330,568  

Cost of sales

     (57,282 )     (55,543 )     (168,614 )     (166,003 )
    


 


 


 


Gross profit

     55,842       56,757       167,551       164,565  

Research and development expense

     (4,048 )     (4,280 )     (12,530 )     (13,086 )

Selling and administrative expense

     (30,177 )     (31,512 )     (88,877 )     (87,343 )

Other operating income

     900       —         900       —    
    


 


 


 


Earnings from continuing operations before interest and income taxes

     22,517       20,965       67,044       64,136  

Net interest expense:

                                

Interest income

     331       662       1,220       1,068  

Interest expense

     (4,656 )     (4,662 )     (13,640 )     (14,046 )
    


 


 


 


Net interest expense

     (4,325 )     (4,000 )     (12,420 )     (12,978 )
    


 


 


 


Earnings from continuing operations before income taxes

     18,192       16,965       54,624       51,158  

Income tax expense

     (6,003 )     (6,023 )     (18,754 )     (18,333 )
    


 


 


 


Earnings from continuing operations

     12,189       10,942       35,870       32,825  

Earnings from discontinued operations, net (less applicable income taxes of $0, $442, $472 and $1,364, respectively)

     —         804       876       2,444  

Gain on sale of discontinued operations, net (less applicable income taxes of $0, $0, $515 and $0, respectively)

     —         —         15,338       —    
    


 


 


 


Net earnings

   $ 12,189     $ 11,746     $ 52,084     $ 35,269  
    


 


 


 


Net earnings per common share:

                                

Basic:

                                

Earnings from continuing operations

   $ 0.43     $ 0.38     $ 1.26     $ 1.16  

Earnings from discontinued operations

     —         0.03       0.03       0.09  

Gain on sale of discontinued operations

     —         —         0.54       —    
    


 


 


 


Basic net earnings per common share

   $ 0.43     $ 0.41     $ 1.83     $ 1.25  
    


 


 


 


Diluted:

                                

Earnings from continuing operations

   $ 0.42     $ 0.38     $ 1.25     $ 1.16  

Earnings from discontinued operations

     —         0.03       0.03       0.09  

Gain on sale of discontinued operations

     —         —         0.53       —    
    


 


 


 


Diluted net earnings per common share

   $ 0.42     $ 0.41     $ 1.81     $ 1.25  
    


 


 


 


Weighted average number of common shares and equivalents outstanding:

                                

Basic

     28,588       28,315       28,494       28,128  

Diluted

     28,815       28,625       28,806       28,306  

 

The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.

 

1


Table of Contents

ProQuest Company and Subsidiaries

Consolidated Balance Sheets

As of October 2, 2004, January 3, 2004, and September 27, 2003

(In thousands)

 

     October 2,
2004
(Unaudited)


    January 3,
2004


    September 27,
2003
(Unaudited)


 
ASSETS                         

Current assets:

                        

Cash and cash equivalents

   $ 970     $ 4,023     $ 3,855  

Accounts receivable, net

     113,476       94,242       127,055  

Inventory, net

     4,995       4,939       5,551  

Other current assets

     62,576       43,035       42,208  
    


 


 


Total current assets

     182,017       146,239       178,669  

Property, plant, equipment, and product masters, at cost

     409,266       395,225       383,027  

Accumulated depreciation and amortization

     (216,605 )     (214,480 )     (203,365 )
    


 


 


Net property, plant, equipment, and product masters

     192,661       180,745       179,662  

Long-term receivables

     5,599       5,106       4,509  

Goodwill

     308,214       303,693       300,905  

Identifiable intangibles, net

     16,377       9,435       7,627  

Purchased and developed software, net

     46,323       55,005       54,658  

Other assets

     15,752       23,813       24,291  
    


 


 


Total assets

   $ 766,943     $ 724,036     $ 750,321  
    


 


 


LIABILITIES AND SHAREHOLDERS’ EQUITY                         

Current liabilities:

                        

Notes payable

   $ —       $ 300     $ —    

Accounts payable

     38,811       49,156       48,664  

Accrued expenses

     39,543       39,428       39,202  

Current portion of monetized future billings

     25,219       25,583       24,950  

Deferred income

     114,392       121,890       123,978  
    


 


 


Total current liabilities

     217,965       236,357       236,794  
    


 


 


Long-term liabilities:

                        

Long-term debt

     194,600       191,000       234,050  

Monetized future billings, less current portion

     42,194       46,835       47,848  

Other liabilities

     68,460       62,444       58,517  
    


 


 


Total long-term liabilities

     305,254       300,279       340,415  
    


 


 


Shareholders’ equity:

                        

Common stock ($.001 par value, 29,174 shares issued and 28,587 shares outstanding at October 2, 2004, 28,964 shares issued and 28,378 shares outstanding at January 3, 2004, and 28,900 shares issued and 28,342 shares outstanding at September 27, 2003)

     29       28       28  

Capital surplus

     314,835       310,461       308,744  

Unearned compensation on restricted stock

     (261 )     —         —    

Notes receivable for stock purchases

     (291 )     (279</